Searched for
EXPERIMENTAL ANTIBODY
Ebola cases increase almost 40% in week as death toll passes 200An Ebola outbreak in Congo and Uganda has claimed over 200 lives. This is the worst outbreak at this stage, with thousands of potential con...
First AI-designed 'universal vaccine' tested in humans: UK researchersA groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
Health insurers can't reject Covid claims for antibody cocktail therapy: IrdaiInsurers have been ordered by the regulator to assess claims denied or deductions made in all such cases and take appropriate action to pay...
Experimental mRNA vaccine for HIV shows promise in animalsThe research, which was carried out by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), Moderna and other i...
Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...
Germany to use Corona meds that helped Donald TrumpGermany will become the first European Union country to start using the same experimental antibodies treatment credited with helping Donald...
2nd study testing a COVID-19 antibody drug has a setbackTests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is...
Eli Lilly antibody drug fails in a COVID-19 study; others go onIndependent monitors had paused enrolment in the study two weeks ago because of a possible safety issue. But on Monday, the National Instit...
GSK to widen COVID-19 antibody treatment trial after safety clearanceThe long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation, typically...
Lilly says antibody drug cuts COVID-19 hospitalization, may seek emergency use nodOf the total 302 patients treated with the Lilly drug, five or 1.7%, had to be hospitalized or required an emergency room visit. That compa...
Use of plasma therapy successful, claims Pune hospitalConvalescent Plasma Therapy is an experimental procedure where plasma from the blood of a recovered COVID-19 patient is transfused to a cri...
Scientists create antibody that claims to defeat coronavirus in labMore research is needed to see whether the findings are confirmed in a clinical setting and how precisely the antibody defeats the virus.
Lucknow hospital begins plasma therapy to treat COVID-19 positive patientsThe doctor from Orai in Uttar Pradesh was administered the plasma donated by a woman doctor from Canada who was the first COVID-19 patient ...
Experimental Ebola vaccine found safe, effectiveThe experimental vaccine for Ebola, VSV-ZEBOV, has common side effects like site pain and transient fever that appeared and resolved within...
10 new antibodies found against cancerThey work by inhibiting the body's blood vessel formation close to the tumour, which is thereby cut off from oxygen and nutrient supply.
Ebola vaccine safe for use in Africa, say scientists from NIAIDScientists from the NIAID have developed two experimental DNA vaccines that code for Ebola virus proteins from the Zaire and Sudan strains.